Our in vivo data were consistent with the findings of the in vitro study, confirming the antitumor effects of β-elemene in lung cancer and regulation of miR155-5p, FOXO3a, and IGFBP1 expression. This evidence concerns the gene FOXO3 and lung carcinoma.